Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Kewaunee Scientific (KEQU) EBITDA (2016 - 2025)

Historic EBITDA for Kewaunee Scientific (KEQU) over the last 16 years, with Q4 2025 value amounting to $4.1 million.

  • Kewaunee Scientific's EBITDA fell 737.48% to $4.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $19.7 million, marking a year-over-year increase of 2011.85%. This contributed to the annual value of $17.8 million for FY2025, which is 285.54% down from last year.
  • Latest data reveals that Kewaunee Scientific reported EBITDA of $4.1 million as of Q4 2025, which was down 737.48% from $4.8 million recorded in Q3 2025.
  • Kewaunee Scientific's 5-year EBITDA high stood at $8.5 million for Q2 2025, and its period low was -$2.9 million during Q4 2021.
  • Moreover, its 5-year median value for EBITDA was $2.4 million (2023), whereas its average is $2.3 million.
  • Per our database at Business Quant, Kewaunee Scientific's EBITDA crashed by 2617272.73% in 2021 and then surged by 106161.62% in 2023.
  • Kewaunee Scientific's EBITDA (Quarter) stood at -$2.9 million in 2021, then surged by 126.12% to $755000.0 in 2022, then surged by 576.69% to $5.1 million in 2023, then fell by 13.21% to $4.4 million in 2024, then dropped by 7.37% to $4.1 million in 2025.
  • Its EBITDA stands at $4.1 million for Q4 2025, versus $4.8 million for Q3 2025 and $8.5 million for Q2 2025.